Similar articles for PMID: 27417648

Year	Number of Results
2003	1
2004	1
2006	1
2008	2
2009	5
2010	1
2011	4
2012	10
2013	7
2014	13
2015	14
2016	13
2017	14
2018	16
2019	9
2020	11
2021	9
2022	3
2023	1
2024	0

1

The Predictive Value of Early Assessment After 1 Cycle of Induction Chemotherapy with 18F-FDG PET/CT and Diffusion-Weighted MRI for Response to Radical Chemoradiotherapy in Head and Neck Squamous Cell Carcinoma.

Wong KH, Panek R, Welsh L, Mcquaid D, Dunlop A, Riddell A, Murray I, Du Y, Chua S, Koh DM, Bhide S, Nutting C, Oyen WJ, Harrington K, Newbold KL. Wong KH, et al. J Nucl Med. 2016 Dec;57(12):1843-1850. doi: 10.2967/jnumed.116.174433. Epub 2016 Jul 14. J Nucl Med. 2016. PMID: 27417648 Free article. Clinical Trial.

2

Changes in multimodality functional imaging parameters early during chemoradiation predict treatment response in patients with locally advanced head and neck cancer.

Wong KH, Panek R, Dunlop A, Mcquaid D, Riddell A, Welsh LC, Murray I, Koh DM, Leach MO, Bhide SA, Nutting CM, Oyen WJ, Harrington KJ, Newbold KL. Wong KH, et al. Eur J Nucl Med Mol Imaging. 2018 May;45(5):759-767. doi: 10.1007/s00259-017-3890-2. Epub 2017 Nov 21. Eur J Nucl Med Mol Imaging. 2018. PMID: 29164301 Free PMC article.

3

Correlations between DW-MRI and ¹⁸ F-FDG PET/CT parameters in head and neck squamous cell carcinoma following definitive chemo-radiotherapy.

Connor S, Sit C, Anjari M, Szyszko T, Dunn J, Pai I, Cook G, Goh V. Connor S, et al. Cancer Rep (Hoboken). 2021 Aug;4(4):e1360. doi: 10.1002/cnr2.1360. Epub 2021 May 7. Cancer Rep (Hoboken). 2021. PMID: 33960739 Free PMC article.

4

Correlation between fluorodeoxyglucose hotspots on pretreatment positron emission tomography/CT and preferential sites of local relapse after chemoradiotherapy for head and neck squamous cell carcinoma.

Chaput A, Calais J, Robin P, Thureau S, Bourhis D, Modzelewski R, Schick U, Vera P, Salaün PY, Abgral R. Chaput A, et al. Head Neck. 2017 Jun;39(6):1155-1165. doi: 10.1002/hed.24738. Epub 2017 Mar 6. Head Neck. 2017. PMID: 28263422

5

Predictive value of quantitative diffusion-weighted imaging and 18-F-FDG-PET in head and neck squamous cell carcinoma treated by (chemo)radiotherapy.

Martens RM, Noij DP, Koopman T, Zwezerijnen B, Heymans M, de Jong MC, Hoekstra OS, Vergeer MR, de Bree R, Leemans CR, de Graaf P, Boellaard R, Castelijns JA. Martens RM, et al. Eur J Radiol. 2019 Apr;113:39-50. doi: 10.1016/j.ejrad.2019.01.031. Epub 2019 Feb 4. Eur J Radiol. 2019. PMID: 30927958

6

Response evaluation after chemoradiotherapy for advanced nodal disease in head and neck cancer using diffusion-weighted MRI and 18F-FDG-PET-CT.

Schouten CS, de Graaf P, Alberts FM, Hoekstra OS, Comans EF, Bloemena E, Witte BI, Sanchez E, Leemans CR, Castelijns JA, de Bree R. Schouten CS, et al. Oral Oncol. 2015 May;51(5):541-7. doi: 10.1016/j.oraloncology.2015.01.017. Epub 2015 Feb 26. Oral Oncol. 2015. PMID: 25725587

7

Early prediction of survival following induction chemotherapy with DCF (docetaxel, cisplatin, 5-fluorouracil) using FDG PET/CT imaging in patients with locally advanced head and neck squamous cell carcinoma.

Abgral R, Le Roux PY, Keromnes N, Rousset J, Valette G, Gouders D, Leleu C, Mollon D, Nowak E, Querellou S, Salaün PY. Abgral R, et al. Eur J Nucl Med Mol Imaging. 2012 Dec;39(12):1839-47. doi: 10.1007/s00259-012-2213-x. Epub 2012 Aug 16. Eur J Nucl Med Mol Imaging. 2012. PMID: 22895863 Clinical Trial.

8

The predictive value of ¹⁸F-FDG PET-CT for assessing the clinical outcomes in locally advanced NSCLC patients after a new induction treatment: low-dose fractionated radiotherapy with concurrent chemotherapy.

Mattoli MV, Massaccesi M, Castelluccia A, Scolozzi V, Mantini G, Calcagni ML. Mattoli MV, et al. Radiat Oncol. 2017 Jan 5;12(1):4. doi: 10.1186/s13014-016-0737-0. Radiat Oncol. 2017. PMID: 28057034 Free PMC article.

9

Diffusion-Weighted MRI in the Assessment of Early Treatment Response in Patients with Squamous-Cell Carcinoma of the Head and Neck: Comparison with Morphological and PET/CT Findings.

Martins EB, Chojniak R, Kowalski LP, Nicolau UR, Lima EN, Bitencourt AG. Martins EB, et al. PLoS One. 2015 Nov 12;10(11):e0140009. doi: 10.1371/journal.pone.0140009. eCollection 2015. PLoS One. 2015. PMID: 26562784 Free PMC article. Clinical Trial.

10

Diffusion-weighted MRI and ¹⁸F-FDG PET/CT in assessing the response to neoadjuvant chemoradiotherapy in locally advanced esophageal squamous cell carcinoma.

Xu X, Sun ZY, Wu HW, Zhang CP, Hu B, Rong L, Chen HY, Xie HY, Wang YM, Lin HP, Bai YR, Ye Q, Ma XM. Xu X, et al. Radiat Oncol. 2021 Jul 19;16(1):132. doi: 10.1186/s13014-021-01852-z. Radiat Oncol. 2021. PMID: 34281566 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Results by year

Text availability

Article attribute

Article type

Publication date

101 results

Results by year